큐렉소
Financials
Valuation Metrics
큐렉소's Market Cap is ₩3693B. At end of 2025 it was ₩5347B. Ranked #546 of 2,436 in KR market (top 22%), #215 of 1,649 on KOSDAQ (top 13%), #6 of 10 in Consumer Staples Distribution & Retail (top 60%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 369.28B KRW | KR#546/2,436 Sec#6/10 |
| Revenue | 70.92B KRW | KR#1,602/2,436 Sec#10/10 |
| Net Income | 2.14B KRW | KR#1,344/2,436 Sec#9/10 |
| Total Assets | 104.25B KRW | KR#1,716/2,436 Sec#9/10 |
| Net Assets | 98.28B KRW | KR#1,412/2,436 Sec#8/10 |
| Employees | 99 | KR#1,631/2,436 Sec#7/10 |
| Value | ||
| P/E | 172.82x | KR#1,465/2,436 Sec#10/10 |
| P/B | 3.76x | KR#2,186/2,436 Sec#10/10 |
| P/S | 5.21x | KR#2,151/2,436 Sec#10/10 |
| EV/EBITDA | 581.26x | KR#1,558/2,436 Sec#10/10 |
| FCF Yield | -3.72% | KR—/2,436 Sec—/10 |
| Profitability | ||
| ROE | 2.17% | KR#1,310/2,436 Sec#8/10 |
| ROA | 2.05% | KR#1,129/2,436 Sec#7/10 |
| Op. Margin | 0.85% | KR#1,501/2,436 Sec#10/10 |
| Revenue Growth | -18.34% | KR#2,035/2,436 Sec#10/10 |
| Earnings Growth | -58.08% | KR#1,242/2,436 Sec#9/10 |
| Financial Health | ||
| Debt Ratio | 106.07% | KR#368/2,436 Sec#2/10 |
| Total Debt | 0 KRW | KR—/2,436 Sec—/10 |
| FCF | -13.74B KRW | KR#1,807/2,436 Sec#10/10 |
| Cash | 16.90B KRW | KR#1,346/2,436 Sec#10/10 |
| Current Ratio | 16.73x | KR#40/2,436 Sec#1/10 |
| Net Debt/EBITDA | -27.87x | KR#24/2,436 Sec#1/10 |
| Performance | ||
| 1Y Return | 5.92% | KR#606/2,436 Sec#4/10 |
| 1M Return | 1.36% | KR#746/2,436 Sec#3/10 |
| From 52W High | -60.31% | KR#1,723/2,436 Sec#9/10 |
| 1Y MDD | -64.32% | KR#1,660/2,436 Sec#9/10 |
| Trading | ||
| Volume | 287,211 shares | KR#421/2,436 Sec#1/10 |
| Foreign Own. | 5.74% | KR#735/2,436 Sec#6/10 |
| Per Share | ||
| EPS | 52 KRW | KR#1,447/2,436 Sec#9/10 |
| BPS | 2,382 KRW | KR#1,942/2,436 Sec#10/10 |
Company Info
Established in 1992 and listed on KOSDAQ in 2002, this company is a specialized medical robot enterprise, planning global business expansion with a local subsidiary in India by 2025. Its medical robot business division operates the orthopedic surgical robot CUVIS-Joint, rehabilitation treatment robot Morning Walk, artificial joint prosthesis implant business, and food ingredient trading. The company addresses the demand for rehabilitation robots driven by an aging population, expands its product range through contracts with US implant specialized enterprises, and pursues medical robot technology innovation and business diversification. Curexo, established in 1992, is headquartered in Seoul Metropolitan City, Songpa-gu.